An update on antiphospholipid syndrome
E Xourgia, MG Tektonidou - Current Rheumatology Reports, 2021 - Springer
Abstract Purpose of Review To review the recent available evidence on epidemiology,
pathogenesis, clinical phenotypes, and management of antiphospholipid syndrome (APS) …
pathogenesis, clinical phenotypes, and management of antiphospholipid syndrome (APS) …
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
Eur J Clin Invest 2010; 40 (5): 451–464 Abstract Background Antiphospholipid syndrome
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts
KJ Lackner, N Müller-Calleja - Expert review of clinical immunology, 2019 - Taylor & Francis
Introduction: Even though our understanding of the antiphospholipid syndrome (APS) has
improved tremendously over the last decades, we are still not in a position to replace …
improved tremendously over the last decades, we are still not in a position to replace …
Antiphospholipid syndrome: a clinical perspective
Antiphospholipid syndrome (APS) is a thromboinflammatory disease with a variety of clinical
phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification …
phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification …
Antiphospholipid syndrome
K Schreiber, S Sciascia, PG De Groot… - Nature reviews Disease …, 2018 - nature.com
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …
Update on antiphospholipid syndrome: ten topics in 2017
I Cavazzana, L Andreoli, M Limper… - Current Rheumatology …, 2018 - Springer
Abstract Purpose of Review This review focuses on new clinical aspects of antiphospholipid
syndrome (APS) in the last 5 years. Recent Findings The pathogenesis of APS is related to …
syndrome (APS) in the last 5 years. Recent Findings The pathogenesis of APS is related to …
Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome
CO Brock, AS Brohl, SG Običan - Birth Defects Research Part C …, 2015 - Wiley Online Library
Antiphospholipid syndrome (APLS) is a complex systemic disease with a wide variety of
clinical manifestations. In the obstetric population, recurrent early pregnancy loss, fetal loss …
clinical manifestations. In the obstetric population, recurrent early pregnancy loss, fetal loss …
Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies
C Comarmond, P Cacoub - Autoimmunity Reviews, 2013 - Elsevier
Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis and pregnancy
morbidity in association with the persistent presence of circulating antiphospholipid …
morbidity in association with the persistent presence of circulating antiphospholipid …
Antiphospholipid syndrome
M Khamashta, M Taraborelli, S Sciascia… - Best practice & research …, 2016 - Elsevier
Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy …
occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy …
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
JS Knight, Y Kanthi - Seminars in immunopathology, 2022 - Springer
Antiphospholipid syndrome (APS) is an autoimmune thrombophilia propelled by circulating
antiphospholipid antibodies that herald vascular thrombosis and obstetrical complications …
antiphospholipid antibodies that herald vascular thrombosis and obstetrical complications …